Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures

Journal of the American College of Cardiology

Volumn 44, Issue 6, 2004, Pages 1210-1214

  Jeremias, Allen ^a,b   Baim, Donald S ^a,c   Ho, Kalon K L ^a,b   Chauhan, Manish ^b   Carrozza Jr , Joseph P ^a   Cohen, David J ^a,b   Popma, Jeffrey J ^c   Kuntz, Richard E ^a,c   Cutlip, Donald E ^a,b  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; THROMBOSIS;

AGED; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERIOSCLEROSIS; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4444352396     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.06.051     Document Type: Article

References (16)

1. J.F. Saucedo, R. Mehran, G Dangas Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting J Am Coll Cardiol 35 2000 1134 1141
2. A.D. Kugelmass, D.J. Cohen, M Moscucci Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting Am J Cardiol 74 1994 748 754
3. G.W. Stone, R. Mehran, G. Dangas, A.J. Lansky, R. Kornowski, M.B. Leon Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7,147 patients Circulation 104 2001 642 647
4. A.E. Abdelmeguid, E.J. Topol, P.L. Whitlow, S.K. Sapp, S.G. Ellis Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions Circulation 94 1996 1528 1536
5. T.Q. Kong, C.J. Davidson, S.N. Meyers, J.T. Tauke, M.A. Parker, R.O. Bonow Prognostic implication of creatine kinase elevation following elective coronary artery interventions JAMA 277 1997 461 466
6. S.G. Ellis, D. Chew, A. Chan, P.L. Whitlow, J.P. Schneider, E.J. Topol Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy Circulation 106 2002 1205 1210
7. D.R. Holmes Jr., P.B. Berger Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctlets: what's behind this new lexicon and what does it add? Circulation 104 2001 627 629
8. D.E. Cutlip, M.J. Ricciardi, F.S Ling Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction Am J Cardiol 92 2003 977 980
9. D.S. Baim, D.E. Cutlip, S.K Sharma Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) Circulation 97 1998 322 331
10. J.P. Ioannidis, E. Karvouni, D.G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J Am Coll Cardiol 42 2003 1406 1411
11. R.A. Harrington, A.M. Lincoff, R.M Califf Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT) J Am Coll Cardiol 25 1995 1693 1699
12. R. Mehran, G. Dangas, G.S Mintz Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2,256 patients Circulation 101 2000 604 610
13. C.M. Gibson, S.A. Murphy, S.J Marble Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy Am Heart J 143 2002 106 110
14. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998;352:87-92.
15. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial Lancet 356 2000 2037 2044
16. J.C. Blankenship, K.N. Sigmon, K.S. Pieper, C. O'Shea, B.E. Tardiff, J.E. Tcheng Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT (Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II trial Am J Cardiol 88 2001 969 973